GoBroad Medical Institute of Hematology

GoBroad Medical Institute of Hematology is a specialized clinical and research organization within the GoBroad Healthcare Group, focusing on hematological malignancies and complex blood disorders. Based in China, the institute operates a network of specialty hospitals that integrate advanced diagnostics, hematopoietic stem cell transplantation, and cellular immunotherapy. It is particularly renowned for its extensive work in CAR-T cell therapy, frequently serving as a primary site for pivotal clinical trials in leukemia and lymphoma. By combining clinical practice with a robust research infrastructure, the institute provides comprehensive care for patients while advancing the development of next-generation hematology treatments.